David Nather
Scientific American
Washington, DC, United States
Contact David
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by David:
Supreme Court Strikes Down Texas Abortion Clinic Regulations
Ruling sets the stage for lawsuits that could overturn similar laws across the U.S. → Read More
5 lessons from the protracted Zika funding fight
Washington is poised to provide money to fight the Zika virus. Here are five things we've learned from the battle to get the funding. → Read More
Next step in Zika funding fight: Wake up the House
House Republicans say they're just not hearing a lot of urgency from their constituents on Zika virus, even in districts most likely to be hit hard. → Read More
Obama administration to launch microbiome initiative
The White House on Friday is announcing a new National Microbiome Initiative to advance the study of microbes across different ecosystems. → Read More
FDA issues sweeping regulations for e-cigarettes for first time
The FDA issued a sweeping set of tobacco rules that would regulate e-cigarettes, cigars, and other products for the first time. → Read More
A native son brings Detroit’s health department back to life
Dr. Abdul El-Sayed, the son of Egyptian immigrants, took over an office that had been gutted and privatized. He was told: "Rebuild it." → Read More
Windfall for cancer research sets off a scramble for clout
With the administration swinging behind Vice President Joe Biden’s “moonshot” effort, cancer advocacy organizations see a window of opportunity opening. → Read More
Congress adjourns without voting on emergency Zika measure
The adjournment followed appeals from top Democrats, including the House minority leader, for Congress to remain in Washington for a vote on the measure. → Read More
Democrats to House: Deal with Zika, opioids before recess
Top Democrats don't want the US House to go home for spring recess until it approves emergency funds for the Zika virus and the opioids crisis. → Read More
Sanders proposes cash prize for companies to make AIDS drugs affordable
Bernie Sanders's new plan would award $3 billion each year to companies developing HIV/AIDS drugs. → Read More
Obama’s emergency request for Zika funding stalls in Congress
The emergency money the Obama administration wants to fight the Zika virus is stuck in Congress — and so far, there's no sign that congressional Republicans are about to budge. → Read More
Obama to lay out next steps in precision medicine initiative
President Obama is set to hold a summit Thursday to discuss what lies ahead for his year-old precision medicine initiative. → Read More
Health of presidential candidates could be factor in election
The health of presidential candidates — an issue that perennially comes up in campaigns — will likely become an issue in the 2016 race. → Read More
Public supports government restrictions on drug prices
Large majorities of Americans believe that the prices of prescription drugs have become unreasonable, and that anger is leading to widespread support for government action to keep costs down, including letting Medicare negotiate prices with drug companies, according to a new poll by STAT and the Harvard T.H. Chan School of Public Health. → Read More
In poll, most Americans say electronic cigarettes harm health
Most Americans believe electronic cigarettes are harmful to people’s health, according to a new survey — even though scientists have not reached a consensus on the risks of the increasingly popular products, a new poll shows. → Read More
Hillary Clinton takes in big money from drug industry, even as she seeks to cap costs
Donors include two senior executives of a company that recently imposed a massive price increase on one of its drugs. → Read More
Hillary Clinton takes in big money from drug industry, even as she seeks to cap costs
Donors include two senior executives of a company that recently imposed a massive price increase on one of its drugs. → Read More
Bernie Sanders rejects CEO Martin Shkreli’s campaign donation
Turing’s price-hiking executive sent candidate $2,700 in effort to have a sitdown about drug prices. → Read More
Bernie Sanders rejects CEO Martin Shkreli’s campaign donation
Turing’s price-hiking executive sent candidate $2,700 in effort to have a sitdown about drug prices. → Read More
Bernie Sanders rejects CEO Martin Shkreli’s campaign donation
Turing’s price-hiking executive sent candidate $2,700 in effort to have a sitdown about drug prices. → Read More